A total of 30 patients receive the triple drug regimen saquinavir plus zidovudine plus lamivudine until the completion of the analysis after at least 4 weeks of therapy.
To explore the antiviral efficacy, tolerability and safety of saquinavir plus zidovudine plus lamivudine.